A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2025-05-01
DOI
https://doi.org/10.1002/pbc.31692
Citations
1
Primary Topic
Neuroblastoma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

Julie Krystal, Steven G. DuBois, Tanya Watt, Rajen J. Mody et al.
1 citations
Pediatric Blood & Cancer
Neuroblastoma Research and Treatments
1.39
article

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

Julie Krystal, Steven G. DuBois, Tanya Watt, Rajen J. Mody, Chinyere E. Okpara, Frank M. Balis, Daniel A. Morgenstern, Karen O’Hara, James M. Croop, AeRang Kim, Brenda J. Weigel, Elizabeth Fox, Margaret E. Macy, Filemon S. Dela Cruz, Joseph G. Pressey, Kieuhoa T. Vo, Julia Glade Bender, Theodore W. Laetsch, Gregory K. Friedman, Jagadeesh Aluri, Cixin He
article en
1 citations

Abstract

No abstract available for this paper.
Pediatric Blood & CancerVol. 72(7)
Cincinnati Children's Hospital Medical Center (US), University of Minnesota (US), St. Jude Children's Research Hospital (US), Memorial Sloan Kettering Cancer Center (US), Children's Hospital of Philadelphia (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), University of California, San Francisco (US), University of Toronto (CA), Hospital for Sick Children (CA), Riley Hospital for Children (US), University of Alabama at Birmingham (US), Children's Hospital Colorado (US), Center for Cancer and Blood Disorders (US), Cohen Children's Medical Center (US), UCSF Benioff Children's Hospital (US), SickKids Foundation (CA), Eisai (United Kingdom) (GB), Eisai (United States) (US), C. S. Mott Children's Hospital (US), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)
Eisai
Good health and well-being
Openalex Percentile: Top 21%
Neuroblastoma Research and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.